NO972525L - Nye benzimidazolderivater med antihistaminaktivitet - Google Patents

Nye benzimidazolderivater med antihistaminaktivitet

Info

Publication number
NO972525L
NO972525L NO972525A NO972525A NO972525L NO 972525 L NO972525 L NO 972525L NO 972525 A NO972525 A NO 972525A NO 972525 A NO972525 A NO 972525A NO 972525 L NO972525 L NO 972525L
Authority
NO
Norway
Prior art keywords
benzimidazole derivatives
antihistamine activity
new benzimidazole
new
antihistamine
Prior art date
Application number
NO972525A
Other languages
English (en)
Other versions
NO313195B1 (no
NO972525D0 (no
Inventor
Aurelio Orjales
Victor Rubio
Maravillas Bordell
Original Assignee
Espanola Prod Quimicos
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Espanola Prod Quimicos filed Critical Espanola Prod Quimicos
Publication of NO972525D0 publication Critical patent/NO972525D0/no
Publication of NO972525L publication Critical patent/NO972525L/no
Publication of NO313195B1 publication Critical patent/NO313195B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO19972525A 1996-06-04 1997-06-03 Nye benzimidazolderivater med antihistaminaktivitet og farmasöytisk preparat inneholdende disse NO313195B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09601236A ES2124167B1 (es) 1996-06-04 1996-06-04 Nuevos derivados del bencimidazol con actividad antihistaminica.

Publications (3)

Publication Number Publication Date
NO972525D0 NO972525D0 (no) 1997-06-03
NO972525L true NO972525L (no) 1997-12-05
NO313195B1 NO313195B1 (no) 2002-08-26

Family

ID=8295035

Family Applications (2)

Application Number Title Priority Date Filing Date
NO19972525A NO313195B1 (no) 1996-06-04 1997-06-03 Nye benzimidazolderivater med antihistaminaktivitet og farmasöytisk preparat inneholdende disse
NO2011008C NO2011008I2 (no) 1996-06-04 2011-05-24 Bilastine eller et addisjonssalt derav

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO2011008C NO2011008I2 (no) 1996-06-04 2011-05-24 Bilastine eller et addisjonssalt derav

Country Status (27)

Country Link
US (1) US5877187A (no)
EP (1) EP0818454B1 (no)
JP (1) JP4218991B2 (no)
CN (1) CN1105716C (no)
AR (1) AR008386A1 (no)
AT (1) ATE264317T1 (no)
AU (1) AU725700B2 (no)
BR (1) BR9703276A (no)
CA (1) CA2206754C (no)
CZ (1) CZ289278B6 (no)
DE (2) DE122011000006I1 (no)
DK (1) DK0818454T3 (no)
ES (1) ES2124167B1 (no)
FR (1) FR11C0023I2 (no)
HR (1) HRP970307B1 (no)
HU (1) HU227598B1 (no)
IN (1) IN186319B (no)
LU (1) LU91798I2 (no)
MX (1) MXPA97004127A (no)
NO (2) NO313195B1 (no)
PL (1) PL188908B1 (no)
PT (1) PT818454E (no)
RU (1) RU2182150C2 (no)
SI (1) SI0818454T1 (no)
TR (1) TR199700464A2 (no)
TW (1) TW438794B (no)
ZA (1) ZA974893B (no)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000001679A1 (fr) 1998-07-01 2000-01-13 Takeda Chemical Industries, Ltd. Regulateurs du recepteur associe aux retinoides
TR200101498T2 (tr) 1998-11-27 2001-11-21 Basf Aktiengesellschaft İkameli benzimidazoller ve parp inhibitörleri olarak kullanımları
ES2151442B1 (es) * 1999-01-11 2001-07-01 Espanola Prod Quimicos Nuevo derivado del bencenoetanol.
US6826561B2 (en) 2000-05-22 2004-11-30 Broadcom Corporation Method and apparatus for performing a binary search on an expanded tree
JP5142448B2 (ja) * 2002-04-19 2013-02-13 ファエス・ファルマ・ソシエダッド・アノニマ ４−［２−［１−（２−エトキシエチル）−１Ｈ−ベンズイミダゾール−２−イル］−１−ピペリジニル］エチル］−α，α−ジメチルベンゼノ酢酸の多形体
US20070188330A1 (en) * 2006-01-24 2007-08-16 Morhard Robert C System and method for detecting, monitoring, tracking and identifying explosive materials using ID marks
US7247623B2 (en) * 2005-08-19 2007-07-24 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with non-drying antihistamines
CN104402773A (zh) 2008-02-12 2015-03-11 柳韩洋行 2-甲基-2’-苯基丙酸衍生物的制备方法和中间体化合物
JP2010013472A (ja) * 2009-09-09 2010-01-21 Faes Farma Sa ４−［２−［１−（２−エトキシエチル）−１Ｈ−ベンズイミダゾール−２−イル］−１−ピペリジニル］エチル］−α，α−ジメチルベンゼノ酢酸の多形体
CN102675101B (zh) * 2012-05-16 2014-01-29 王蕾 2-(4-卤乙基)苯基-2-甲基丙酸酯的制备方法及合成比拉斯汀的方法
CZ307500B6 (cs) 2012-08-15 2018-10-24 Zentiva, K.S. Způsob přípravy derivátu 2-methyl-2´-fenylpropionové kyseliny využívající nové intermediáty
US20140271504A1 (en) * 2013-03-15 2014-09-18 Hercules Incorporated Composition and method of producing personal care compositions with improved deposition properties
CN103214455B (zh) * 2013-03-30 2018-08-31 北京万全德众医药生物技术有限公司 一种比拉斯汀的制备方法
CN103214454A (zh) * 2013-03-30 2013-07-24 北京万全德众医药生物技术有限公司 一种比拉斯汀晶型及制备方法
WO2014188453A2 (en) * 2013-05-24 2014-11-27 Msn Laboratories Private Limited Novel process for the preparation of 2-[4-(2-{4-[1-(2-ethoxyethyl)-1h-benzimidazol-2-yl]-1-piperidinyl}ethyl) phenyl]-2-methylpropanoic acid
CN103351380B (zh) * 2013-06-30 2019-01-22 北京万全德众医药生物技术有限公司 一种制备比拉斯汀的方法
CN104447683A (zh) * 2013-09-12 2015-03-25 天津市汉康医药生物技术有限公司 一种稳定的比拉斯汀化合物
CN103896915A (zh) * 2014-04-01 2014-07-02 中国药科大学 苯并咪唑类衍生物、其制备方法及其在医药上的应用
EP3040334A1 (en) 2014-12-29 2016-07-06 Faes Farma, S.A. New benzimidazole derivatives as antihistamine agents
CN106349214B (zh) * 2015-07-13 2020-11-03 南京长澳医药科技有限公司 一种比拉斯汀杂质的制备方法
ES2600827B9 (es) * 2015-07-24 2018-03-28 Urquima, S.A Formas cristalinas de bilastina y procedimientos para su preparación
CN105272977A (zh) * 2015-09-19 2016-01-27 万全万特制药江苏有限公司 一种制备比拉斯汀中间体的方法
EP3170817A1 (en) 2015-11-20 2017-05-24 Faes Farma, S.A. Co-crystals of benzimidazole compounds
EP3170816A1 (en) 2015-11-20 2017-05-24 Faes Farma, S.A. Supersaturated compositions of benzimidazole compounds
WO2017167949A1 (en) 2016-04-01 2017-10-05 Krka, D.D., Novo Mesto Crystalline forms of bilastine
EP3452462A4 (en) * 2016-05-05 2019-10-23 MSN Laboratories Private Limited, R&D Center SOLID STATE FORMS OF 2- [4- (2- {4- [1- (2-ETHOXYETHYL) -1H-BENZIMIDAZOL-2-YL] -1-PIPERIDINYL} ETHYL) PHENYL] -2-METHYLPROPANOIC ACID AND PREPARATION METHOD THEREOF
CN107365298A (zh) * 2017-03-14 2017-11-21 罗欣生物科技（上海）有限公司 一种2‑甲基‑2’‑苯基丙酸衍生物的制备方法
CN109456316A (zh) * 2017-09-06 2019-03-12 万全万特制药江苏有限公司 一种比拉斯汀杂质的制备方法
ES2813561T3 (es) 2017-09-07 2021-03-24 Tiefenbacher Alfred E Gmbh & Co Kg Composición farmacéutica en comprimido que comprende bilastina
MA50247B1 (fr) 2017-10-16 2021-02-26 Faes Farma Sa Compositions aqueuses comprenant de la bilastine et du mométasone
WO2019097091A1 (en) 2017-12-18 2019-05-23 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Pharmaceutical tablet composition comprising bilastine form 3 and a water-soluble filler
EP3470062B1 (en) 2017-12-18 2020-10-28 Alfred E. Tiefenbacher (GmbH & Co. KG) Pharmaceutical tablet composition comprising bilastine polymorphic form 3 and magnesium aluminometasilicate
CN111727035B (zh) 2018-01-18 2024-05-28 费斯制药股份有限公司 包含比拉斯汀、β-环糊精和至少一种胶凝剂的眼用组合物
CN109081827A (zh) * 2018-11-06 2018-12-25 北京天弘天达医药科技股份有限公司 一种比拉斯汀的制备方法及应用
EP3725298A1 (en) 2019-04-16 2020-10-21 Faes Farma, S.A. Stable and preserved pharmaceutical compositions of bilastine
EP4188339A1 (en) 2020-07-30 2023-06-07 Faes Farma, S.A. Decongestant drug delivery system
CN112110893A (zh) * 2020-10-28 2020-12-22 山东齐环医药科技有限公司 一种比拉斯汀的制备方法
EP4247331A1 (en) 2020-11-18 2023-09-27 BioPharma Synergies, S. L. Orodispersible powder composition comprising an antihistamine compound
EP4267109A1 (en) 2020-12-23 2023-11-01 Noucor Health S.A. A non-micronized bilastine composition
WO2023156559A1 (en) 2022-02-17 2023-08-24 Faes Farma, S.A. Bilastine composition for once-daily parenteral administration

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2048109B1 (es) * 1992-07-20 1994-12-16 Espanola Prod Quimicos Procedimiento de preparacion de nuevos derivados piperidicos del bencimidazol.
ES2284740T3 (es) * 1992-08-03 2007-11-16 Sepracor Inc. Carboxilato de terfenadina y el tratamiento de la irritacion cutanea.
CN1275916C (zh) * 1993-06-25 2006-09-20 阿温蒂斯公司 用于制备抗组胺哌啶衍生物的新中间体

Also Published As

Publication number Publication date
CA2206754C (en) 2007-01-23
CZ289278B6 (cs) 2001-12-12
CZ172397A3 (en) 1997-12-17
CA2206754A1 (en) 1997-12-04
DE122011000006I1 (de) 2011-06-16
PL320358A1 (en) 1997-12-08
ES2124167B1 (es) 1999-09-16
FR11C0023I1 (no) 2011-08-19
US5877187A (en) 1999-03-02
TR199700464A3 (tr) 1997-12-21
AU725700B2 (en) 2000-10-19
EP0818454A1 (en) 1998-01-14
FR11C0023I2 (fr) 2012-03-16
DK0818454T3 (da) 2004-07-12
HU9700997D0 (en) 1997-07-28
LU91798I2 (fr) 2011-05-23
AU2467297A (en) 1997-12-11
ES2124167A1 (es) 1999-01-16
MXPA97004127A (es) 2005-07-25
DE69728608T2 (de) 2005-04-21
TR199700464A2 (xx) 1997-12-21
HU227598B1 (en) 2011-09-28
ATE264317T1 (de) 2004-04-15
JPH1059961A (ja) 1998-03-03
NO313195B1 (no) 2002-08-26
IN186319B (no) 2001-08-04
SI0818454T1 (en) 2004-08-31
EP0818454B1 (en) 2004-04-14
NO972525D0 (no) 1997-06-03
RU2182150C2 (ru) 2002-05-10
HRP970307B1 (en) 2002-02-28
PT818454E (pt) 2004-08-31
PL188908B1 (pl) 2005-05-31
AR008386A1 (es) 2000-01-19
NO2011008I2 (no) 2012-05-14
BR9703276A (pt) 2004-08-17
CN1176964A (zh) 1998-03-25
NO2011008I1 (no) 2011-06-06
HRP970307A2 (en) 1998-04-30
JP4218991B2 (ja) 2009-02-04
CN1105716C (zh) 2003-04-16
HUP9700997A1 (hu) 1999-09-28
ZA974893B (en) 1997-12-30
TW438794B (en) 2001-06-07
DE69728608D1 (de) 2004-05-19

Similar Documents

Publication Publication Date Title
NO972525L (no) Nye benzimidazolderivater med antihistaminaktivitet
PT900210E (pt) Derivados azahexano heterociclicos com actividade antviral
NO983356L (no) Nye 19-nor-pregnenderivater
DK1676845T3 (da) Nye quinazolinderivater
DE69525418T2 (de) Benzimidazol-derivate
NO20000226L (no) Nye spiroazabicykliske heterocykliske forbindelser
IS5285A (is) Benzímídasól afleiður
NO970088D0 (no) Acylazolonderivater med anti-Helicobacteraktivitet
DK1237857T3 (da) Nye Phenalkyloxyphenylderivater
NO20011790L (no) Nye imidazoler med anti-inflammatorisk aktivitet
NO970086L (no) Heterocykliske azolonderivater med anti-Helicobacteraktivitet
DE69933135D1 (de) Benzimidazolderivate mit vitronectinrezeptor-antagonistischer wirkung
NO960268D0 (no) Nye dialkoksypyridinylbenzimidazolderivater
DK0931087T3 (da) Nye pyranosidderivater
NO20023148D0 (no) Nye indolderivater
NO20024504L (no) Nye imidazolderivater med anti-inflammatorisk aktivitet
NO983918D0 (no) Nye ureaderivater
DK0946548T3 (da) Nye heterocykliske substituerede pyrrolidinamidderivater
NO970498D0 (no) Benzimidazolderivater med dopaminergisk aktivitet
NO995430D0 (no) Nye heterosykliske forbindelser
DK0886645T3 (da) Nye 19-nor-pregnen-derivater
NO960267D0 (no) Nye substituerte benzimidazoler

Legal Events

Date Code Title Description
SPCF Filing of supplementary protection certificate

Free format text: PRODUCT NAME: ZILAS; NAT. REG. NO/DATE: 09-6621 20110413; FIRST REG. NO/DATE: IS/1/10/002/01 20100923

Spc suppl protection certif: 2011008

Filing date: 20110524

SPCG Granted supplementary protection certificate

Free format text: PRODUCT NAME: ZILAS; NAT. REG. NO/DATE: 09-6621 20110413; FIRST REG. NO/DATE: IS/1/10/002/01 20100923

Spc suppl protection certif: 2011008

Filing date: 20110524

Extension date: 20220603

MK1K Patent expired
SPCX Expiry of an spc

Spc suppl protection certif: 2011008